HIV Treatment Reduces Accelerated Biological Aging by Nearly Four Years

Growing evidence suggests that people with HIV experience accelerated biological aging, driven by chronic inflammation and immune dysregulation, contributing to elevated risks of cardiovascular and other age‑related diseases. 

At ESCMID Global 2026, researchers presented new data showing that ART can partially reverse this accelerated aging at the molecular level, reducing biological age by nearly four years.

CMS Town Hall Meeting on Biktarvy Price Negotiations: Comments by Joseph Cherabie

CMS Town Hall Meeting on Biktarvy Price Negotiations: Comments by Kevin Herwig

Comments provided by Kevin Herwig, HIV+Hepatitis Policy Institute, during the Centers for Medicare and Medicaid Services Town Hall Meeting on Biktarvy Price Negotiations, April 22, 2026.

Patients With HIV May Have High Prevalence of Long COVID

The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.

Recommendations for Incorporating Geriatrics Into HIV Care Include Attention to Both Body and Mind

Of the nearly 1.1 million people living with HIV in the United States in 2022, an estimated 54% were over 50 years old, according to the Centers for Disease Control and Prevention (CDC). Yet we are not doing enough to meet the needs of this population: A recent CDC study found that the country was on pace to miss all of its 2025 goals for improving the quality of life for people living with HIV age 50 and older.

Nearly 20% of New HIV Diagnoses Occur Among Older Adults

Patients aged 50 and older who were newly diagnosed with HIV often reported heterosexual transmission and were more often women when compared with those younger than 50, according to an analysis of patients in New York State that was published in JAIDS.

PDAB: Balancing the Scale

The Role of PDABs in Drug Pricing and Healthcare Stakeholder Impacts

Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) Impact on Patients, Drug Pricing, and Innovation

This HealthHIV Advocacy paper explores the function of Prescription Drug Affordability Boards (PDABs) in managing prescription drug costs, considering perspectives of patients, providers, and payers to ensure equitable access to vital medications while controlling healthcare expenses. 

Putting the Brakes on Accelerated Aging of Bone, Muscle from HIV Infection, Treatment

Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.

Brain Aging in HIV Affected by Adverse Social Determinants of Health, Comorbidities

Social determinants of health were found to be associated with brain aging among patients with HIV infection, according to results of a retrospective case-control study published in The Lancet HIV.

Use of Antiretroviral Therapy in Nursing Home Residents with HIV

Antiretroviral therapies are essential in HIV care. As people living with HIV age and their presence in nursing homes increases, it is critical to evaluate the quality of HIV care.

How Evidence-Based Health Promotion Programs Can Support Adults with HIV/AIDS

As HIV treatment has advanced and more people are managing HIV as a chronic condition, evidence-based health promotion programs can provide support.